Progression of impending retinal vein occlusion to the ischemic variant following intravitreal ranibizumab

Reem Z. Renno
2018 New Frontiers in Ophthalmology  
An 82-year-old woman who had experienced two episodes of amaurosis fugax in her left eye presented with vision loss. She was diagnosed with impending retinal vein occlusion (RVO) of the left eye and received an intravitreal injection of ranibizumab. One month after this injection she was diagnosed with ischemic RVO. At 8-weeks post-presentation, extremely ischemic features were observed of severe vascular attenuation and extensive retinal capillary obliteration. She experienced no visual improvement over the following several months.
doi:10.15761/nfo.1000200 fatcat:gv65hlc5znbvnln2zqj35dcnpy